Effectiveness and Tolerability of Eptinezumab: a Prospective, Multicentric, Cohort Study
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of eptinezumab as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of migraine without aura, migraine with aura, or chronic migraine according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III);
• Good compliance to study procedures;
• Availability of headache diary at least of the preceding months before enrolment;
• At least 8 monthly migraine days.
Locations
Other Locations
Italy
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
RECRUITING
Florence
AOU Policlinico Di Modena
NOT_YET_RECRUITING
Modena
Contact Information
Primary
Luigi F Iannone, mD
luigifrancesco.iannone@unifi.it
3896969606
Backup
Simona Guerzoni, MD
Time Frame
Start Date: 2024-03-26
Estimated Completion Date: 2026-04
Participants
Target number of participants: 100
Treatments
Episodic migraine
Patients affected by migraine with an episodic pattern (\< 15 monthly migraine days) with or without aura according to ICHD-III criteria.
Chronic migraine
atients affected by chronic migraine (\> 15 monthly headache days with at least 8 days with migraine features) according to ICHD-III criteria.
Related Therapeutic Areas
Sponsors
Collaborators: Azienda Ospedaliero Universitaria Policlinico Modena, Azienda Ospedaliera S. Maria della Misericordia, Euganea Health Unit, Padua, Italy, Azienda Policlinico Umberto I, Azienda Ospedaliero-Universitaria di Parma, Auxologico San Luca, Asst Degli Spedali Civili Di Brescia, Università degli Studi dell'Aquila, University of Campania Luigi Vanvitelli, Ospedale Santo Stefano, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Cliniche Humanitas Gavazzeni, IRCCS National Neurological Institute C. Mondino Foundation, A.O.U. Città della Salute e della Scienza, University of Roma La Sapienza, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Società Italiana per lo Studio delle Cefalee
Leads: University of Florence